Predictive value of maternal-IgG avidity for congenital human cytomegalovirus infection

被引:39
作者
Bodéus, M [1 ]
Goubau, P [1 ]
机构
[1] Univ Catholique Louvain, Dept Microbiol, Virol Unit, B-1200 Brussels, Belgium
关键词
avidity index; congenital infection; HCMV; pregnancy;
D O I
10.1016/S1386-6532(98)00009-2
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Human cytomegalovirus (HCMV) is now the most common cause of viral intrauterine infection. Fetal damage is mostly linked to maternal primary infection. It is therefore important to differentiate primary from recurrent or persistent HCMV infection in pregnant females. For this purpose, IgM tests are not reliable enough and the measurement of the IgG avidity appears to be presently the best method. Objective: To evaluate the performance of the measurement of HCMV-IgG avidity by a 8 M urea denaturation assay in predicting congenital infection in the offspring. Study design: Seventy-eight women were included in this study on the basis of a HCMV-IgM positive or equivocal result on a first serum during pregnancy, but without a documented seroconversion history. The IgG avidity was measured and correlated with the outcome of the pregnancy. Results: In eight cases of HCMV in utero infection the maternal HCMV-IgG avidity index was below 50%. One case of HCMV in utero infection was observed despite a high avidity index during the second trimester of the pregnancy. High or intermediate HCMV-IgG avidity indexes during the first trimester of pregnancy were not associated with a congenital infection. Conclusions: Even in the presence of an IgM positive result, an HCMV-IgG avidity index above 65% on a serum obtained during the first trimester of pregnancy could reasonably be considered as a good indicator of past HCMV infection. In these conditions invasive prenatal diagnosis is not necessary. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:3 / 8
页数:6
相关论文
共 30 条
[1]   AVIDITIES OF IGG DIRECTED AGAINST VIRAL CAPSID ANTIGEN OR EARLY ANTIGEN - USEFUL MARKERS FOR SIGNIFICANT EPSTEIN-BARR-VIRUS SEROLOGY [J].
ANDERSSON, A ;
VETTER, V ;
KREUTZER, L ;
BAUER, G .
JOURNAL OF MEDICAL VIROLOGY, 1994, 43 (03) :238-244
[2]   DIFFERENTIATION OF PRIMARY CYTOMEGALOVIRUS-INFECTION FROM REACTIVATION USING THE UREA DENATURATION TEST FOR MEASURING ANTIBODY AVIDITY [J].
BLACKBURN, NK ;
BESSELAAR, TG ;
SCHOUB, BD ;
OCONNELL, KF .
JOURNAL OF MEDICAL VIROLOGY, 1991, 33 (01) :6-9
[3]   Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant women [J].
Bodeus, M ;
Feyder, S ;
Goubau, P .
CLINICAL AND DIAGNOSTIC VIROLOGY, 1998, 9 (01) :9-16
[4]   ANTIVIRAL ANTIBODY-RESPONSES AND INTRAUTERINE TRANSMISSION AFTER PRIMARY MATERNAL CYTOMEGALOVIRUS-INFECTION [J].
BOPPANA, SB ;
BRITT, WJ .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05) :1115-1121
[5]  
DONNER C, 1993, OBSTET GYNECOL, V82, P481
[6]  
Dussaix E, 1996, PATHOL BIOL, V44, P405
[7]   THE OUTCOME OF CONGENITAL CYTOMEGALOVIRUS-INFECTION IN RELATION TO MATERNAL ANTIBODY STATUS [J].
FOWLER, KB ;
STAGNO, S ;
PASS, RF ;
BRITT, WJ ;
BOLL, TJ ;
ALFORD, CA .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (10) :663-667
[8]   Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women [J].
GrangeotKeros, L ;
Mayaux, MJ ;
Lebon, P ;
Freymuth, F ;
Eugene, G ;
Stricker, R ;
Dussaix, E .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (04) :944-946
[9]   DETECTION OF HUMAN PARVOVIRUS-B19-SPECIFIC IGM AND IGG ANTIBODIES USING A RECOMBINANT VIRAL VP1 ANTIGEN EXPRESSED IN INSECT CELLS AND ESTIMATION OF TIME OF INFECTION BY TESTING FOR ANTIBODY AVIDITY [J].
GRAY, JJ ;
COHEN, BJ ;
DESSELBERGER, U .
JOURNAL OF VIROLOGICAL METHODS, 1993, 44 (01) :11-23
[10]   A PROSPECTIVE-STUDY OF PRIMARY CYTOMEGALOVIRUS-INFECTION DURING PREGNANCY - FINAL REPORT [J].
GRIFFITHS, PD ;
BABOONIAN, C .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1984, 91 (04) :307-315